help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huber-Lang, M.
Right arrow Articles by Ward, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber-Lang, M.
Right arrow Articles by Ward, P. A.
(American Journal of Pathology. 2002;161:1849-1859.)
© 2002 American Society for Investigative Pathology

Generation of C5a by Phagocytic Cells

Markus Huber-Lang*, Ellen M. Younkin*, J. Vidya Sarma*, Niels Riedemann*, Stephanie R. McGuire*, Kristina T. Lu*, Robin Kunkel*, John G. Younger{dagger}, Firas S. Zetoune* and Peter A. Ward*

From the Departments of Pathology* and Emergency Medicine,{dagger} University of Michigan Medical School, Ann Arbor, Michigan

The complement activation product, C5a, is a powerful phlogistic factor. Using antibodies to detect human or rat C5a, incubation at pH 7.4 of human blood neutrophils or rat alveolar macrophages (AMs) with C5 in the presence of phorbol 12-myristate 13-acetate (PMA) led to generation of C5a. Rat AMs activated with lipopolysaccharide also generated C5a from C5. With activated neutrophils, extensive cleavage of C5 occurred, whereas activated macrophages had much more selective proteolytic activity for C5. Peripheral blood human or rat mononuclear cells and rat alveolar epithelial cells when stimulated with phorbol ester all failed to demonstrate an ability to cleave C5, suggesting a specificity of C5 cleavage by phagocytic cells. With rat AMs, C5a generation was time-dependent and was blocked if AMs were pretreated with inhibitors of transcription or protein synthesis (actinomycin D or cycloheximide). Similar treatment of activated human polymorphonuclear leukocytes only partially reduced C5a generation after addition of C5. C5a generated by activated AMs was biologically (chemotactically) active. This generation was sensitive to serine protease inhibitors but not to other classes of inhibitors. These data indicate that phagocytic cells, especially lung macrophages, can generate C5a from C5. In the context of the lung, this may represent an important C5a-generating pathway that is independent of the plasma complement system.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. Fukuoka, H.-Z. Xia, L. B. Sanchez-Munoz, A. L. Dellinger, L. Escribano, and L. B. Schwartz
Generation of Anaphylatoxins by Human {beta}-Tryptase from C3, C4, and C5
J. Immunol., May 1, 2008; 180(9): 6307 - 6316.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. A. Ward
Role of the complement in experimental sepsis
J. Leukoc. Biol., March 1, 2008; 83(3): 467 - 470.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Garantziotis, J. W. Hollingsworth, R. B. Ghanayem, S. Timberlake, L. Zhuo, K. Kimata, and D. A. Schwartz
Inter-{alpha}-Trypsin Inhibitor Attenuates Complement Activation and Complement-Induced Lung Injury
J. Immunol., September 15, 2007; 179(6): 4187 - 4192.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Mihai, M. T. Chiriac, K. Takahashi, J. M. Thurman, V. M. Holers, D. Zillikens, M. Botto, and C. Sitaru
The Alternative Pathway of Complement Activation Is Critical for Blister Induction in Experimental Epidermolysis Bullosa Acquisita
J. Immunol., May 15, 2007; 178(10): 6514 - 6521.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Skokowa, S. R. Ali, O. Felda, V. Kumar, S. Konrad, N. Shushakova, R. E. Schmidt, R. P. Piekorz, B. Nurnberg, K. Spicher, et al.
Macrophages Induce the Inflammatory Response in the Pulmonary Arthus Reaction through G{alpha}i2 Activation That Controls C5aR and Fc Receptor Cooperation
J. Immunol., March 1, 2005; 174(5): 3041 - 3050.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Markiewski, D. Mastellos, R. Tudoran, R. A. DeAngelis, C. W. Strey, S. Franchini, R. A. Wetsel, A. Erdei, and J. D. Lambris
C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury
J. Immunol., July 15, 2004; 173(2): 747 - 754.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. C. Riedemann, R.-F. Guo, and P. A. Ward
A key role of C5a/C5aR activation for the development of sepsis
J. Leukoc. Biol., December 1, 2003; 74(6): 966 - 970.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. G. Younger, S. Shankar-Sinha, M. Mickiewicz, A. S. Brinkman, G. A. Valencia, J. V. Sarma, E. M. Younkin, T. J. Standiford, F. S. Zetoune, and P. A. Ward
Murine Complement Interactions with Pseudomonas aeruginosa and Their Consequences During Pneumonia
Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 432 - 438.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. W. Strey, M. Markiewski, D. Mastellos, R. Tudoran, L. A. Spruce, L. E. Greenbaum, and J. D. Lambris
The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration
J. Exp. Med., September 15, 2003; 198(6): 913 - 923.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.